Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells

Cornea

Volumn 24, Issue 8, 2005, Pages 1004-1009

  Suzuki, Tomo ^a   Sullivan, David A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Cornea; Cytokine; Dry eye; Estrogen; Matrix metalloproteinase

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLACEBO;

ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOKINE RELEASE; DNA SYNTHESIS; DRY EYE; ENZYME RELEASE; ESTROGEN THERAPY; EXPOSURE; EYE INFLAMMATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SYMPTOMATOLOGY;

CELLS, CULTURED; CYTOKINES; EPITHELIUM, CORNEAL; ESTRADIOL; HUMANS; MATRIX METALLOPROTEINASES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 28044472795     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000160973.04072.a5     Document Type: Article

References (48)

1. Yeh S, Pflugfelder SC, Stern ME. Pathological effects of lacrimal keratoconjunctivitis on the ocular surface. In: Pflugfelder SC, Beuerman RW, Stern ME, eds. Dry Eye and Ocular Surface Disorders. New York: Marcel Dekker; 2004:191-203.
2. Kumar A, Zhang J, Yu FS. Innate immune response of corneal epithelial cells to staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci. 2004;45:3513-3522.
3. Lang R, Song PI, Legat FJ, et al. Human corneal epithelial cells express functional PAR-1 and PAR-2. Invest Ophthalmol Vis Sci. 2003;44:99-105.
4. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18:293-309.
5. Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000;41:1703-1709.
6. Kim HS, Shang T, Chen Z, et al. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Exp Eye Res. 2004;79:263-274.
7. Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001;73:449-459.
8. Song XJ, Li DQ, Farley W, et al. Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2003;44:4223-4229.
9. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
10. Tishler M, Yaron I, Geyer O, et al. Elevated tear interleukin-6 levels in patients with Sjögren syndrome. Ophthalmology. 1998;105:2327-2329.
11. Thakur A, Willcox MD. Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. Exp Eye Res. 1998;67:9-19.
12. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002;506:989-998.
13. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114-1119.
14. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
15. Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and the prevalence of dry eye syndrome. JAMA. 2001;286:2114-2119.
16. Pivirotto LA, Cissel DS, Keeting PE. Sex hormones mediate interleukin-1 beta production by human osteoblastic HOBIT cells. Mol Cell Endocrinol. 1995;111:67-74.
17. Bengtsson AK, Ryan EJ, Giordano D, et al. 17β-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood. 2004;104:1404-1410.
18. Kanda N, Watanabe S. 17β-estradiol enhances the production of granulocyte-macrophage colony-stimulating factor in human keratinocytes. J Invest Dermatol. 2004;123:329-337.
19. Puistola U, Westerlund A, Kauppila A, et al. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril. 1995;64:81-87.
20. Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001;12:241-251.
21. Wilson MJ, Woodson M, Wiehr C, et al. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat. Exp Mol Pathol. 2004;77:7-17.
22. Suzuki T, Kinoshita Y, Tachibana M, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res. 2001;22:28-33.
23. Waltman SR, Burde RM, Berrios J. Prevention of corneal homograft rejection by estrogens. Transplantation. 1971;11:194-196.
24. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
25. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986;83: 2496-2500.
26. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 2002;29:23-39.
27. Marin-Castano ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2003;44:50-59.
28. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-1362.
29. Fibbe WE, van der Meer JW, Falkenburg JH, et al. Interleukin 1 and poly(rl)poly(rc) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Exp Hematol. 1989;17:229-234.
30. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
31. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J Immunol. 1998;161:3340-3346.
32. Ma X, Li Y, Zhang S, et al. Effect of interleukin-1β on aromatase activity in human osteoblast-like cells. Zhonghua Fu Chan Ke Za Zhi. 2002;37: 478-480.
33. Purohit A, Singh A, Ghilchik MW, et al. Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts. Br J Cancer. 2003;88:630-635.
34. Jakob F, Siggelkow H, Homann D, et al. Local estradiol metabolism in osteoblast- and osteoclast-like cells. J Steroid Biochem Mol Biol. 1997;61: 167-174.
35. Ruben M. Contact lenses and oral contraceptives. BMJ. 1966;1:1110.
36. Riss B, Binder S, Riss P, et al. Corneal sensitivity during the menstrual cycle. Br J Ophthalmol. 1982;66:123-126.
37. Kiely PM, Carney LG, Smith G. Menstrual cycle variations of corneal topography and thickness. Am J Optom Physiol Opt. 1983;60:822-829.
38. Imafidon CO, Imafidon JE. Contact lenses in pregnancy. Br J Obstet Gynaecol. 1992;99:865-868.
39. Gurwood AS, Gurwood I, Gubman DT, et al. Idiosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci. 1995;72:29-33.
40. Verbeck B. Augenbefunde und stoffwechselverhalten bei einnahme von ovulationshemmern. Klin Monatsbl Augenheilkd. 1973;162:612-621.
41. Christ T, Marquardt R, Stodtmeister R, et al. Zur Beeinflussung der tränenfilmaufreibzeit durch hormonale kontrazeptiva. Fortschr Ophthalmol. 1986;83:108-111.
42. Sorrentino C, Affinito P, Mattace Raso F, et al. Effect of hormone replacement therapy on postmenopausal ocular function. Minerva Ginecol. 1998;50:19-24.
43. 45Ca in rats after administration of a single dose of estrogens during the first days of postnatal life. Graefes Arch Clin Exp Ophthalmol. 1974;191:85-91.
44. McCarty CA, Ng I, Waldron B, et al. Relation of hormone and menopausal status to outcomes following excimer laser photorefractive keratectomy in women. Melbourne Excimer Laser Group. Aust N Z J Ophthalmol. 1996;24:215-222.
45. Midelfart A. Women and men - same eyes? Acta Ophthalmol Scand. 1996; 74:589-592.
46. Chizek DJ, Franceschetti AT. Oral contraceptives: their side effects and ophthalmological manifestations. Surv Ophthalmol. 1969;14:90-105.
47. Decherney AH. The use of birth control pills in women with medical disorders. Clin Obstet Gynecol. 1981;24:965-975.
48. Yolton DP, Yolton RL, Lopez R, et al. The effects of gender and birth control pill use on spontaneous blink rates. J Am Optom Assoc. 1994;65:763-770.